The stock of Renalytix Plc ADR (RNLX) has seen a 24.25% increase in the past week, with a -7.06% drop in the past month, and a 149.37% flourish in the past quarter. The volatility ratio for the week is 10.20%, and the volatility levels for the past 30 days are at 9.85% for RNLX. The simple moving average for the past 20 days is 1.90% for RNLX’s stock, with a -37.52% simple moving average for the past 200 days.
Is It Worth Investing in Renalytix Plc ADR (NASDAQ: RNLX) Right Now?
Additionally, the 36-month beta value for RNLX is 3.05. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for RNLX is 46.30M and currently, short sellers hold a 1.46% ratio of that float. The average trading volume of RNLX on May 02, 2024 was 1.91M shares.
RNLX) stock’s latest price update
Renalytix Plc ADR (NASDAQ: RNLX) has experienced a rise in its stock price by 14.01 compared to its previous closing price of 0.69. However, the company has seen a gain of 24.25% in its stock price over the last five trading days. InvestorPlace reported 2024-03-25 that Let’s keep it real in this joint – you should generally avoid stocks under $1. Yes, they’re “cheap” but that’s not necessarily a good thing.
Analysts’ Opinion of RNLX
Many brokerage firms have already submitted their reports for RNLX stocks, with H.C. Wainwright repeating the rating for RNLX by listing it as a “Buy.” The predicted price for RNLX in the upcoming period, according to H.C. Wainwright is $30 based on the research report published on January 18, 2022 of the previous year 2022.
BTIG Research, on the other hand, stated in their research note that they expect to see RNLX reach a price target of $24. The rating they have provided for RNLX stocks is “Buy” according to the report published on January 04th, 2022.
Guggenheim gave a rating of “Buy” to RNLX, setting the target price at $28 in the report published on October 04th of the previous year.
RNLX Trading at -9.96% from the 50-Day Moving Average
After a stumble in the market that brought RNLX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -80.43% of loss for the given period.
Volatility was left at 9.85%, however, over the last 30 days, the volatility rate increased by 10.20%, as shares sank -2.34% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +5.33% upper at present.
During the last 5 trading sessions, RNLX rose by +24.25%, which changed the moving average for the period of 200-days by -77.87% in comparison to the 20-day moving average, which settled at $0.7743. In addition, Renalytix Plc ADR saw 102.56% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for RNLX
Current profitability levels for the company are sitting at:
- -15.8 for the present operating margin
- 0.06 for the gross margin
The net margin for Renalytix Plc ADR stands at -17.36. The total capital return value is set at 14.39. Equity return is now at value -9009.47, with -199.59 for asset returns.
Based on Renalytix Plc ADR (RNLX), the company’s capital structure generated 16.07 points at debt to capital in total, while cash flow to debt ratio is standing at -4.26. The debt to equity ratio resting at -1.07. The interest coverage ratio of the stock is 12.3.
Currently, EBITDA for the company is -35.5 million with net debt to EBITDA at -0.09. When we switch over and look at the enterprise to sales, we see a ratio of 19.94. The receivables turnover for the company is 1.76for trailing twelve months and the total asset turnover is 0.21. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.59.
Conclusion
In conclusion, Renalytix Plc ADR (RNLX) has seen mixed performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
